Latest news
CORE Biomedicine Deepens Precision Oncology Pipeline With $21 Million Funding Round and Eisai Licensing Deal - TipRanksTipRanks · Sat, 01 Aug 2026 16:03:02 GMTCORE Biomedicine Raises $21 Million Series A and Secures AMED Grant to Advance Lineage-Based Cancer Drugs - TipRanksTipRanks · Tue, 28 Jul 2026 13:34:39 GMTCORE Biomedicine Secures $21 Million Series A Venture Financing and Receives AMED Grant Award to Advance Novel Cancer Therapeutics - PR NewswirePR Newswire · Tue, 28 Jul 2026 07:00:00 GMT